30.2 C
Kuwait City
October 28, 2020
Gulflance
Home » WHO defends data after concluding Gilead’s remdesivir flopped Covid trial – News
Khaleejtimes

WHO defends data after concluding Gilead’s remdesivir flopped Covid trial – News

Source link


Gilead was given data from the United Nations health agency’s trial 10 days ago, to give it an opportunity to react.

A World Health Organization (WHO) trial that concluded Gilead Sciences Inc. remdesivir did not significantly help Covid-19 patients is reliable, a scientist who evaluated it said on Friday, as the US company criticized its methodology.

“It’s a reliable result, don’t let anybody tell you otherwise, because they’ll try to,” Richard Peto, an independent statistician hired by the WHO to evaluate its Solidarity trial, told reporters, adding that any benefit of remdesivir may be due to chance.

Gilead has questioned the findings that concluded remdesivir does not help patients who have been admitted to hospital, saying the “emerging (WHO) data appears inconsistent”. Gilead was given data from the United Nations health agency’s trial 10 days ago, to give it an opportunity to react.

 





Click here to read more news from @khaleejtimes

Related posts

Everyone is responsible, health top priority: Sheikh Mohammed – News

gulflance

Coronavirus: Trump says US ‘terminating’ relationship with World Health Organization – News

gulflance

15 Saudi prisoners to be released by Houthis: Arab Coalition – News

gulflance

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Please spend a minute

Gulflance Poll

Which is worst social media?
Vote Now
close-link

You're currently offline